|Bid||0.0000 x 3000|
|Ask||0.0000 x 2200|
|Day's Range||0.3810 - 0.4250|
|52 Week Range||0.3700 - 2.1400|
|Beta (5Y Monthly)||2.03|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 13, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.45|
Subscribe to Yahoo Finance Plus to view Fair Value for IMCC
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany announces that a complaint was in the Ontario Superior Court of Justice in Canada by Michael Wiener, 35 Oak Holdings Ltd. and MW Investments Ltd. (collectively the "MYM Shareholder Plaintiffs") against IMC Cannabis Corp. and its board of directors and officers, (collectively, "IMC"). A copy of this complaint was delivered to IMC on November 17, 2023.
IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the third quarter ended September 30, 2023. All amounts are reported in Canadian dollars and compared to the quarter ended September 30, 2022, unless otherwise stated.
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended September 30, 2023, on Monday, November 13, 2023 before the market opens.